Skip to main content

Table 6 GIPAP: 3-year survival for patients entering the programme in 2005

From: Benefits of global partnerships to facilitate access to medicines in developing countries: a multi-country analysis of patients and patient outcomes in GIPAP

 

2005

2006

2007

 

Q1

Q2

Q3

Q4

Q1

Q2

Q3

Q4

Q1

Q2

Q3

Q4

Wave 1 (entering quarter 1, 2005)

Active

850

742

701

680

649

626

603

576

559

557

533

520

Not reported/Closed

 

108

149

170

201

224

247

274

291

293

317

330

Total

850

850

850

850

850

850

850

850

850

850

850

850

Wave 2 (entering quarter 2, 2005)

Active

0

866

752

717

695

655

630

594

574

588

557

537

Not reported/Closed

  

114

149

171

211

236

272

292

278

309

329

Total

0

866

866

866

866

866

866

866

866

866

866

866

Wave 3 (entering quarter 3, 2005)

Active

0

0

910

795

752

723

704

664

649

639

608

606

Not reported/Closed

   

115

158

187

206

246

261

271

302

304

Total

0

0

910

910

910

910

910

910

910

910

910

910

Wave 4 (entering quarter 4, 2005)

Active

0

0

0

903

821

775

745

710

695

680

656

654

Not reported/Closed

    

82

128

158

193

208

223

247

249

Total

0

0

0

903

903

903

903

903

903

903

903

903

All 4 waves (quarters 1 - 4, 2005)

Total Active

850

1608

2363

3095

2917

2779

2682

2544

2477

2464

2354

2317

Total Not reported/Closed

0

108

263

434

612

750

847

985

1052

1065

1175

1212

Total number of patients

850

1716

2626

3529

3529

3529

3529

3529

3529

3529

3529

3529

  1. Source: The authors from GIPAP.